Log In
Print
BCIQ
Print
Print this Print this
 

BIIB037

  Manage Alerts
Collapse Summary General Information
Company Neurimmune Therapeutics AG
DescriptionHuman anti-amyloid beta mAb
Molecular Target Beta amyloid
Mechanism of Action 
Latest Stage of DevelopmentPhase I
IndicationAlzheimer's disease (AD)
Partner

Biogen Idec Inc.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today